Tadashi Ogawa Selected Research

Fibroblast Growth Factors (Fibroblast Growth Factor)

8/2002

Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadashi Ogawa Research Topics

Disease

4	Neoplasms (Cancer) 07/2011 - 08/2002
3	Rectal Neoplasms (Rectal Cancer) 01/2018 - 03/2015
3	Neoplasm Metastasis (Metastasis) 01/2017 - 07/2011
2	Acute Cholecystitis 07/2020 - 01/2012
2	Inflammation (Inflammations) 01/2020 - 01/2005
2	Carcinoma (Carcinomatosis) 01/2018 - 01/2011
2	Non-alcoholic Fatty Liver Disease 02/2013 - 06/2005
2	Stroke (Strokes) 02/2013 - 03/2008
2	Hyperinsulinism (Hyperinsulinemia) 02/2004 - 08/2003
2	Hyperglycemia 02/2004 - 08/2003
1	Dementia (Dementias) 07/2020
1	Cholecystitis 07/2020
1	Cholelithiasis 07/2020
1	Hernia (Hernias) 06/2020
1	Diarrhea 01/2020
1	Dysbiosis 01/2020
1	Ascites 03/2019
1	Internal Hernia 03/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Overactive Urinary Bladder (Overactive Bladder) 01/2017
1	Testicular Neoplasms (Testicular Cancer) 01/2017
1	Hemangioma (Angioma) 12/2013
1	Diaphragmatic Hernia 12/2013
1	Thrombosis (Thrombus) 11/2011
1	Idiopathic Noncirrhotic Portal Hypertension 11/2011
1	Varicose Veins (Varicose Vein) 11/2011
1	Hemorrhage 11/2011
1	Breast Neoplasms (Breast Cancer) 07/2011
1	Bile Duct Neoplasms (Bile Duct Cancer) 03/2011
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 06/2005
1	Hypertriglyceridemia 02/2004
1	Atherosclerosis 02/2004
1	Obesity 08/2003
1	Insulin Resistance 08/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2002
1	Lung Neoplasms (Lung Cancer) 08/2002

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 01/2020 - 06/2005
1	Polypropylenes (Polypropylene)IBA 06/2020
1	palmitoleic acidIBA 01/2020
1	protectin D1IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	silodosin FDA Link 01/2017
1	naftopidilIBA 01/2017
1	AntigensIBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 04/2016
1	Bile Acids and Salts (Bile Acids)IBA 02/2013
1	CholesterolIBA 02/2013
1	Mitogen-Activated Protein KinasesIBA 03/2011
1	Peptide Hydrolases (Proteases)FDA Link 03/2011
1	NF-kappa B (NF-kB)IBA 03/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2011
1	N-valyltryptophanIBA 03/2008
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2005
1	Amino Acids FDA Link 01/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2005
1	Dietary ProteinsIBA 02/2004
1	Proteins (Proteins, Gene)FDA Link 02/2004
1	AcidsIBA 02/2004
1	Interleukin-12 (IL 12)IBA 02/2004
1	4-(2-pyridyldithio)butyramidineIBA 02/2004
1	Glycine max beta-conglycinin proteinIBA 02/2004
1	Hormones (Hormone)IBA 08/2003
1	EnzymesIBA 08/2003
1	ImmunosorbentsIBA 08/2003
1	ResistinIBA 08/2003
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2002
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2002
1	Angiopoietin-1IBA 08/2002

Therapy/Procedure

3	Therapeutics 07/2011 - 08/2002
2	Laparotomy 07/2020 - 03/2019
2	Laparoscopic Cholecystectomy 07/2020 - 01/2012
2	Lymph Node Excision (Lymph Node Dissection) 03/2019 - 03/2015
2	Neoadjuvant Therapy 01/2018 - 01/2011
2	Radiotherapy 01/2018 - 04/2016
2	Chemoradiotherapy 01/2018 - 04/2016
1	Length of Stay 07/2020
1	Surgical Instruments (Clip) 06/2020
1	Prostatectomy (Retropubic Prostatectomy) 03/2019
1	Hepatectomy 12/2013
1	Splenectomy 11/2011
1	Drug Therapy (Chemotherapy) 07/2011
1	Oral Administration 03/2008